Skip to content
DataLookout
Menu

NCT05394662

Safety and Effectiveness of Juveena™ Hydrogel System Following Transcervical Gynecologic Procedures (TCGP) At High-Risk for Intrauterine Adhesions

StatusCompleted
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 14 versions: 12 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 19, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: 2 to 3
    • Primary endpoint revised
    • Site details revised at 2 of 15 sites
  2. Minor Interventions: Juveena Hydrogel System (Device) to Juveena Hydrogel System (Device), Transcervical Gynecologic Procedures (TCGP) (Procedure)
    • Study title expanded, about 3 words
    v13
  3. Minor Trial status: Active, Not Recruiting to Completed
    • Primary and study completion dates changed from estimate of Apr 15, 2025 to Apr 23, 2025
    • Site details revised at 1 of 15 sites
    v12
  4. Minor Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 17 to 15
    • Primary and study completion dates: Mar 15, 2025 to Apr 15, 2025
    v11
  5. Minor Study sites: 16 to 17v10
Show 6 earlier versionsHide 6 earlier versions
  1. Notable Primary and study completion dates: Mar 15, 2024 to Mar 15, 2025v9
  2. Minor Study sites: 12 to 16v8
  3. Notable Eligibility criteria shortened, about 45 words
    • Study sites: 8 to 12
    v7
  4. Notable Eligibility criteria expanded, about 24 wordsv5
  5. Minor Study sites: 7 to 8v4
  6. Notable Lead sponsor: [Redacted] to Rejoni Inc.v3 Show 4 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary and study completion dates: Mar 15, 2024
    • Start date: Aug 11, 2022
    • Study title expanded, about 1 word
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Freedom From Intrauterine Adhesions (IUA)
Timeframe: 8 weeks

Secondary (3)

Change In IUA Severity Among Adhesiolysis Subjects
Severity of IUA
Freedom of IUA With Superiority Margin of 5% Over Control at IUA

Arms and interventions

Transcervical Gynecological Procedure + Juveena HydrogelExperimental

Transcervical Gynecological Procedure + Juveena Hydrogel

Transcervical Gynecological Procedure alone (standard of care)Active comparator

Transcervical Gynecological Procedure alone (standard of care)

Devices: Juveena Hydrogel System

Procedures: Transcervical Gynecologic Procedures (TCGP)

Sites

15 sites in 1 country